MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / Business/Financial News / Delphinus nabs $8 million for breast cancer detection device

Delphinus nabs $8 million for breast cancer detection device

May 25, 2010 By MedCity News Leave a Comment

MedCity News logo

By Brandon Glenn

Delphinus Medical Technologies Inc. received $8 million in funding commitments to further develop an ultrasonic breast cancer detection device that could become an alternative to mammograms.

The funding means that Delphinus can finally begin the process of commercializing its SoftVue device, which has undergone about 10 years of research and development.

Unlike mammography, which is traditionally used to detect breast cancer, the SoftVue doesn’t use radiation or compression. Instead, the device employs ultrasound and computer algorithms to detect breast cancer, including in breast tissue that is too dense for effective use of mammography. With SoftVue, the breast is submerged in warm water and an ultrasound ring surrounds the breast, capturing images through the use of sound waves.

The SoftVue exam takes about a minute and is a “fraction” of the cost associated with a breast MRI, according to the company.

Delphinus is a spinoff created last year by the Detroit-based Barbara Ann Karmanos Cancer Institute, whose researchers created the device. The Karmanos Institute held all of Delphinus’ equity until the $8 million round, which was led by Arboretum Ventures of Ann Arbor, Mich. Farmington Hills, Mich.-based Beringea LLC co-led the deal and was joined by North Coast Technology Investors, according to a statement from Karmanos.

More than 300 women were involved in initial clinical studies of the device. Delphinus has received sale commitments for the device from “several” health institutions that have agreed to be part of the clinical studies, according to the statement.

Right now, the Karmanos Institute has the SoftVue’s only working prototype, but the funding will allow it to design and build the first 10 machines used in clinical studies. Those studies are expected to pave the way for Food & Drug Administration approval of the device, which is necessary before it can be sold in the U.S.

The funding will also allow Delphinus to hire about 20 workers.

The word “delphinus” is Latin for dolphin.

Filed Under: Business/Financial News, Diagnostics, News Well Tagged With: Breast Cancer, Delphinus Medical Technologies Inc.

In case you missed it

  • Employees say Intuitive Surgical, J&J, Stryker best places to work in 2020
  • Eitan Group signs service agreement with Integrated Medical Systems
  • Beta Bionics’ bionic pancreas wins breakthrough status from FDA
  • Sanofi backs away from diabetes partnership with Verily
  • FDA clears Cochlear piezoelectric hearing implant
  • Biolase lands 510(k) for dental hygiene laser
  • Mayo Clinic, W.L. Gore team up on stem cell therapy treatments
  • ViewRay issues urgent field safety notice for MRIdian System Treatment Planning and Delivery System
  • Barry out as InspireMD CEO
  • Report: EtO blood levels higher in Illinois neighbors of Medline sterilization plant
  • FDA clears augmented glenoids for Shoulder Innovations system
  • McKesson names new chief information and technology officer
  • Imperative Care raises $85m
  • CMR Surgical appoints new CEO
  • Peregrine Ventures raises $115m
  • Roche wins CE Mark for blood glucose reading smartphone app
  • Cantel Medical beats The Street in Q1 results

RSS From Medical Design & Outsourcing

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS